Pharmaceutical product manufacture, marketing, trade, and export are all activities of Pfizer Ltd. It produces goods in-house and also works with several independent contract and third-party manufacturers located all throughout the nation. It sells its goods through independent distributors, particularly in India. It ranks as one of India’s largest multinational pharmaceutical corporation.
Financial Results:
- Pfizer Limited reported Total Income for Q4FY23 of ₹ 604 Crores up from ₹ 567 Crore year on year, a rise of 7%.
- Total Expenses for Q4FY23 of ₹ 420 Crores down from ₹ 422 Crores year on year, rise of 0.5%.
- Consolidated Net Profit of ₹ 130 Crores, up 3% from ₹ 126 Crores in the same quarter of the previous year.
- The Earnings per Share is ₹ 28.34, up 3% from ₹ 27.50 in the same quarter of the previous year.